Standard dose pravastatin (40 mg) v high dose atorvastatin (80 mg) for the acute coronary syndrome*
| Outcomes at mean 24 months | Atorvastatin | Pravastatin | RRR (CI) | NNT (CI) |
|---|---|---|---|---|
| *Composite endpoint = all cause death, myocardial infarction (MI), unstable angina (UA) requiring hospital readmission, revascularisation (⩾30 d after randomisation), and stroke; CHD = coronary heart disease. Other abbreviations defined in glossary; RRR, NNT, and CI provided by author. | ||||
| Composite endpoint | 22.4% | 26.3% | 16% (5 to 26) | 19 (11 to 62) |
| CHD death, non-fatal MI, or revascularisation | 19.7% | 22.3% | 14% (2 to 25) | 27 (15 to 230) |
| Revascularisation | 16.3% | 18.8% | 14% (0 to 26) | 33 (17 to 647) |
| UA requiring hospital admission | 3.8% | 5.1% | 29% (5 to 47) | 65 (35 to 436) |